Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 12. April 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16360  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 327189  
   
The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications.
J Ovarian Res
Chen J, Gu Z, Hua K, Zhang Y, Shen F, Zhang M, Zhou G, Ding J.
PMID: 41964086 [PubMed - as supplied by publisher]


Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer Therapy.
AAPS PharmSciTech
Fatima M, AlQahtani F, Kesharwani P.
PMID: 41963751 [PubMed - indexed for MEDLINE]


Neoadjuvant twelve weekly paclitaxel-carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer.
Breast Cancer Res Treat
Leshem Y, Golomb I, Zubkov A, Bar Y, Strulov Shachar S, Lerner S, Keren-Khadmy N, Sonnenblick A.
PMID: 41963621 [PubMed - indexed for MEDLINE]


PARP inhibitors and breast cancer: from therapeutic breakthrough to resistance challenge.
Exp Mol Med
Wang W, Cai C, Qin S, He L, Liang Q, Tang S, Xie J, Long T, Hou J, Kim W, Zhao F.
PMID: 41963466 [PubMed - as supplied by publisher]


Correspondence on "Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer" by Kim et al.
Int J Gynecol Cancer
Song Y, Mao W, Chen Y, Wenren Y.
PMID: 41963199 [PubMed - as supplied by publisher]


Leydig cell ovarian tumour: a rare cause of hyperandrogenism.
BMJ Case Rep
Tseke D, Malkat S, Younes Y, Emmanuel J.
PMID: 41962961 [PubMed - indexed for MEDLINE]


3-POINT CORRECTION FACTOR IMPROVES ACCURACY OF FRAMINGHAM RISK SCORE IN BREAST CANCER SURVIVORS.
Can J Cardiol
Rickard JN, Christensen RAG, Williams JS, Abdel-Qadir H, Small SD, Santa Mina D, Kirkham AA.
PMID: 41962842 [PubMed - as supplied by publisher]


Association between inflammatory biomarkers and depressive symptoms in breast cancer: a systematic review.
Brain Behav Immun
Patel K, Karagiannis SN, Borsini A.
PMID: 41962682 [PubMed - as supplied by publisher]


Past, Present, and Future Perspectives in Estrogen-Receptor-Low Breast Cancer.
Crit Rev Oncol Hematol
Courtès DM, Florea DC, Anchisi S.
PMID: 41962626 [PubMed - as supplied by publisher]


Breast MRI features of idiopathic granulomatous mastitis and invasive breast carcinoma: A single-center comparative study.
Clin Imaging
Erkoc N, Karl, Tokoçin M, Gülkaç BÖ, Kalpako, Cimilli AT.
PMID: 41962447 [PubMed - as supplied by publisher]


Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.
ESMO Open
Curigliano G, O'Shaughnessy J, Bidard FC, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, Carey LA, Okera M, Melo E, Zagouri F, Magallanes-Maciel M, Karadurmus N, Bahadur S, Speck RM, Wang XA, Pradhan K, Macey J, Kitchen H, Fairhurst S, Miller J, Jhaveri KL, Harbeck N.
PMID: 41962306 [PubMed - as supplied by publisher]


Impact of hypofractionated radiotherapy schedules on local control in early breast cancer: A five-year study of boost vs. non-boost protocols.
Appl Radiat Isot
Najafizde N, Elhaie M, Mirlohi SH.
PMID: 41962282 [PubMed - as supplied by publisher]


Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape.
Am Soc Clin Oncol Educ Book
Hennessy MA, Terman E, Idossa D, LeVee A, Leon-Ferre RA, McArthur H, Nanda R.
PMID: 41962061 [PubMed - indexed for MEDLINE]


Breast Cancer Risk Factors and Breast Complaints Among Kenyan Women.
JCO Glob Oncol
Odhiambo LA, Marion AJ, Mwaura WL, Mageto DK, Islam KM, Mwakisha J, Coughlin SS, Ojuka DK.
PMID: 41962057 [PubMed - indexed for MEDLINE]


Multigated DNA Cascade Amplifier for Ultrasensitive Spatiotemporal Imaging of PLS3 mRNA at the Single-Cell Level for Early Detection of Breast Cancer Metastasis.
Anal Chem
Wang K, Liu X, Tang B, Yu H, Liu R, Wen M, Kai T.
PMID: 41961955 [PubMed - as supplied by publisher]


Unveiling the Multifaceted Dynamics of Breast Cancer: A Copula Regression Approach to Modeling and Predicting Outcomes.
PLoS One
Rani H, Mehmood T, Aslam M, Al-Essa LA.
PMID: 41961887 [PubMed - indexed for MEDLINE]


Association of postoperative psychological interventions on compliance and survival in breast cancer patients: A single-center retrospective study.
Medicine (Baltimore)
Dong R, Yu J.
PMID: 41961706 [PubMed - indexed for MEDLINE]


Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women.
JAMA Netw Open
Williamson MR, Whitsel EA, Smith RL, Collins JM, Stewart JD, Jung SY, Harris HR, Feiler MO, Manson JE, Qi L, Schwartz GG.
PMID: 41961496 [PubMed - indexed for MEDLINE]


Primary Inflammatory Myofibroblastic Tumour of the Breast: A Potential Diagnostic Pitfall on Aspiration Cytology.
Cytopathology
Sood N, Gupta R, Ruhi, Gupta S.
PMID: 41960745 [PubMed - as supplied by publisher]


Using deformable registration to assess dosimetric impact of variability in deep inspiration breath hold (DIBH) levels for left breast treatment.
J Appl Clin Med Phys
Ranganathan VT, Gouthro A, Stevens T.
PMID: 41960694 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 327189    Seite 1 von 16360  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1